ReviewJournal for immunotherapy of cancer2022
Defining unique clinical hallmarks for immune checkpoint inhibitor-based therapies.
Olivier Michielin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this paperpooled ittrialcites it